Skip to main content

Table 4 Multivariate analysis of LRFS on quality of life of QLQ-C30 among 501 patients with nasopharyngeal carcinoma

From: Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT

  HR 95%CI P
Age 1.583 0.582–4.302 0.368
Gender 1.017 0.300–3.450 0.978
Marriage 0.479 0.099–2.320 0.360
Education 1.337 0.852–2.098 0.206
Smoking history 1.455 0.512–4.139 0.482
Alcohol history 1.086 0.480–2.458 0.843
T stage 1.267 0.361–4.449 0.712
N stage 1.604 0.616–4.172 0.333
Pre-treatment EBV DNA 1.221 0.491–3.035 0.667
Post-treatment EBV DNA 3.093 0.881–10.857 0.078
Cognitive functioning 0.971 0.951–0.990 0.004
  1. Abbreviations: LRFS Loco regional recurrent free survival, HR Harsard ratio
\